Method for treating blastocystis infection
AssigneeImam Abdulrahman Bin Faisal University
InventorsB. Rabindran JERMY, Vijaya RAVINAYAGAM, Ayman A. ELBADRY
Life of this patent
Estimating the term…
Abstract
A nanomedicinal composition comprising a nanocarrier and an antioxidant. The nanocarrier contains a metal organic framework and a porous silicate and/or aluminosilicate matrix. The antioxidant is disposed in the pores and/or on the surface of the nanocarrier by a solution phase impregnation process. The nanomedicinal composition is used in a method of treating Blastocystis infection.
Claims18
(canceled)
The method of claim 19, wherein the porous silicate and/or aluminosilicate matrix is at least one selected from the group consisting of MCM-41 and KIT-6.
The method of claim 19, wherein the porous silicate and/or aluminosilicate matrix is present in an amount of 1 to 20 wt % based on a total weight of the nanocarrier.
The method of claim 19, wherein the metal organic framework comprises an imidazole of formula I:
- and is substantially free of a benzimidazole of formula II:
The method of claim 19, wherein the antioxidant is at least one selected from the group consisting of quercetin, rutin, coenzyme Q10, gallic acid, resveratrol, and curcumin.
The method of claim 19, wherein the antioxidant is present in the nanomedicinal composition in an amount of 5 to 50 wt %, based on a total weight of nanomedicinal composition.
The method of claim 19, wherein the nanomedicinal composition reduces the viability of Blastocystis organisms by at least 75% when the nanomedicinal composition is present for 24 hours in an amount of 100 to 1000 μg/mL.
16-18. (canceled)
A method for treating an infection by a parasite in the genus Blastocystis in a subject, comprising:
- administering a pharmaceutical composition comprising a nanomedicinal composition to the subject in need of treatment for a Blastocystis infection,
- wherein the nanomedicinal composition comprises a nanocarrier comprising:
- a metal organic framework which is a zeolitic imidazolate framework, and
- a porous silicate and/or aluminosilicate matrix;
- and
- an antioxidant disposed in the pores and/or on a surface of the nanocarrier.
(canceled)
Dependencies are inferred from the claim text.